Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
zebrafish |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Allele |
Name: |
f8 gastrulation arrest |
Allele Type: |
Chemically induced (ENU) |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang JP |
Year: |
2019 |
Journal: |
Genome Biol |
Title: |
Curing hemophilia A by NHEJ-mediated ectopic F8 insertion in the mouse. |
Volume: |
20 |
Issue: |
1 |
Pages: |
276 |
|
•
•
•
•
•
|
Cell Line |
Name: |
F8 |
Derivation . Parent Cell Line . Name: |
D3H |
Cell Line Type: |
ES Cell |
|
•
•
•
•
•
|
Publication |
First Author: |
Chao BN |
Year: |
2016 |
Journal: |
J Thromb Haemost |
Title: |
Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene. |
Volume: |
14 |
Issue: |
2 |
Pages: |
346-55 |
|
•
•
•
•
•
|
Heritable Phenotypic Marker |
Type: |
heritable_phenotypic_marker |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This family consists of several poxvirus F8 proteins. The function of this family is unknown. |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2179073 |
Assay Type: |
RT-PCR |
Annotation Date: |
2002-05-15 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1603911 |
|
Stage: |
TS11 |
Assay Id: |
MGI:2179079 |
Age: |
embryonic day 7.5 |
|
|
Specimen Label: |
F8 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2179073 |
Assay Type: |
RT-PCR |
Annotation Date: |
2002-05-15 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3568928 |
|
Stage: |
TS28 |
Assay Id: |
MGI:2179080 |
Age: |
postnatal adult |
|
|
Specimen Label: |
F8 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2681703 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-12-19 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1757728 |
|
Stage: |
TS28 |
Assay Id: |
MGI:2681778 |
Age: |
postnatal day 21 |
|
|
Specimen Label: |
F8 |
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2681702 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-12-19 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1757728 |
|
Stage: |
TS28 |
Assay Id: |
MGI:2681779 |
Age: |
postnatal day 21 |
|
|
Specimen Label: |
F8 |
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:2681701 |
Assay Type: |
RT-PCR |
Annotation Date: |
2003-12-19 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1757728 |
|
Stage: |
TS28 |
Assay Id: |
MGI:2681780 |
Age: |
postnatal day 21 |
|
|
Specimen Label: |
F8 |
Detected: |
true |
Specimen Num: |
6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hayakawa M |
Year: |
2021 |
Journal: |
Sci Rep |
Title: |
Characterization and visualization of murine coagulation factor VIII-producing cells in vivo. |
Volume: |
11 |
Issue: |
1 |
Pages: |
14824 |
|
•
•
•
•
•
|
Publication |
First Author: |
van Helden PM |
Year: |
2011 |
Journal: |
Blood |
Title: |
Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model. |
Volume: |
118 |
Issue: |
13 |
Pages: |
3698-707 |
|
•
•
•
•
•
|
Publication |
First Author: |
Greene TK |
Year: |
2010 |
Journal: |
Blood |
Title: |
In vivo efficacy of platelet-delivered, high specific activity factor VIII variants. |
Volume: |
116 |
Issue: |
26 |
Pages: |
6114-22 |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
zebrafish |
|
•
•
•
•
•
|
Publication |
First Author: |
Everett LA |
Year: |
2014 |
Journal: |
Blood |
Title: |
Murine coagulation factor VIII is synthesized in endothelial cells. |
Volume: |
123 |
Issue: |
24 |
Pages: |
3697-705 |
|
•
•
•
•
•
|
Publication |
First Author: |
Westrick RJ |
Year: |
2017 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Sensitized mutagenesis screen in Factor V Leiden mice identifies thrombosis suppressor loci. |
Volume: |
114 |
Issue: |
36 |
Pages: |
9659-9664 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
2247
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
2249
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus pahari |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus spretus |
|
•
•
•
•
•
|
Publication |
First Author: |
Elder B |
Year: |
1993 |
Journal: |
Genomics |
Title: |
Sequence of the murine factor VIII cDNA. |
Volume: |
16 |
Issue: |
2 |
Pages: |
374-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Follenzi A |
Year: |
2012 |
Journal: |
Blood |
Title: |
Role of bone marrow transplantation for correcting hemophilia A in mice. |
Volume: |
119 |
Issue: |
23 |
Pages: |
5532-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bi L |
Year: |
1995 |
Journal: |
Nat Genet |
Title: |
Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. |
Volume: |
10 |
Issue: |
1 |
Pages: |
119-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pordes AG |
Year: |
2011 |
Journal: |
Blood |
Title: |
T cell-independent restimulation of FVIII-specific murine memory B cells is facilitated by dendritic cells together with toll-like receptor 7 agonist. |
Volume: |
118 |
Issue: |
11 |
Pages: |
3154-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen Y |
Year: |
2016 |
Journal: |
Blood |
Title: |
The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunity. |
Volume: |
127 |
Issue: |
10 |
Pages: |
1346-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Allacher P |
Year: |
2011 |
Journal: |
Blood |
Title: |
Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9. |
Volume: |
117 |
Issue: |
1 |
Pages: |
259-67 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nielsen AL |
Year: |
2017 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Engineering of a membrane-triggered activity switch in coagulation factor VIIa. |
Volume: |
114 |
Issue: |
47 |
Pages: |
12454-12459 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shi Q |
Year: |
2008 |
Journal: |
Blood |
Title: |
Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity. |
Volume: |
112 |
Issue: |
7 |
Pages: |
2713-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lai JD |
Year: |
2016 |
Journal: |
Blood |
Title: |
Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A. |
Volume: |
127 |
Issue: |
26 |
Pages: |
3439-49 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lipshutz GS |
Year: |
1999 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero. |
Volume: |
96 |
Issue: |
23 |
Pages: |
13324-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bi L |
Year: |
1996 |
Journal: |
Blood |
Title: |
Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. |
Volume: |
88 |
Issue: |
9 |
Pages: |
3446-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ward NJ |
Year: |
2011 |
Journal: |
Blood |
Title: |
Codon optimization of human factor VIII cDNAs leads to high-level expression. |
Volume: |
117 |
Issue: |
3 |
Pages: |
798-807 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wroblewska A |
Year: |
2012 |
Journal: |
Blood |
Title: |
Modification of an exposed loop in the C1 domain reduces immune responses to factor VIII in hemophilia A mice. |
Volume: |
119 |
Issue: |
22 |
Pages: |
5294-300 |
|
•
•
•
•
•
|
Publication |
First Author: |
Steinitz KN |
Year: |
2012 |
Journal: |
Blood |
Title: |
CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice. |
Volume: |
119 |
Issue: |
17 |
Pages: |
4073-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qian J |
Year: |
2000 |
Journal: |
Blood |
Title: |
Prevention and treatment of factor VIII inhibitors in murine hemophilia A. |
Volume: |
95 |
Issue: |
4 |
Pages: |
1324-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Peyron I |
Year: |
2018 |
Journal: |
Cell Immunol |
Title: |
Oxidation of factor VIII increases its immunogenicity in mice with severe hemophilia A. |
Volume: |
325 |
|
Pages: |
64-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bhatt S |
Year: |
2015 |
Journal: |
Exp Hematol |
Title: |
Hepatic stellate cell-conditioned myeloid cells provide a novel therapy for prevention of factor VIII antibody formation in mice. |
Volume: |
43 |
Issue: |
4 |
Pages: |
277-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sack BK |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy. |
Volume: |
7 |
Issue: |
5 |
Pages: |
e37671 |
|
•
•
•
•
•
|
Publication |
First Author: |
Milanov P |
Year: |
2012 |
Journal: |
Blood |
Title: |
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice. |
Volume: |
119 |
Issue: |
2 |
Pages: |
602-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
McIntosh J |
Year: |
2013 |
Journal: |
Blood |
Title: |
Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant. |
Volume: |
121 |
Issue: |
17 |
Pages: |
3335-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sehgal A |
Year: |
2015 |
Journal: |
Nat Med |
Title: |
An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia. |
Volume: |
21 |
Issue: |
5 |
Pages: |
492-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fakharzadeh SS |
Year: |
2000 |
Journal: |
Blood |
Title: |
Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin. |
Volume: |
95 |
Issue: |
9 |
Pages: |
2799-805 |
|
•
•
•
•
•
|
Publication |
First Author: |
Butterfield JSS |
Year: |
2022 |
Journal: |
Mol Ther |
Title: |
IL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV-transduced hepatocytes in hemophilia A mice. |
Volume: |
30 |
Issue: |
12 |
Pages: |
3552-3569 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsui H |
Year: |
2009 |
Journal: |
Blood |
Title: |
A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cells. |
Volume: |
114 |
Issue: |
3 |
Pages: |
677-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Muczynski V |
Year: |
2018 |
Journal: |
Blood |
Title: |
A factor VIII-nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation. |
Volume: |
132 |
Issue: |
11 |
Pages: |
1193-1197 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsui H |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
Delivery of full-length factor VIII using a piggyBac transposon vector to correct a mouse model of hemophilia A. |
Volume: |
9 |
Issue: |
8 |
Pages: |
e104957 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kiouptsi K |
Year: |
2017 |
Journal: |
PLoS One |
Title: |
Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels. |
Volume: |
12 |
Issue: |
8 |
Pages: |
e0183590 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mishra A |
Year: |
2018 |
Journal: |
Int J Exp Pathol |
Title: |
Evaluation of high-fat high-fructose diet treatment in factor VIII (coagulation factor)-deficient mouse model. |
Volume: |
99 |
Issue: |
1 |
Pages: |
46-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu D |
Year: |
2009 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. |
Volume: |
106 |
Issue: |
3 |
Pages: |
808-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Eubanks J |
Year: |
2016 |
Journal: |
Blood |
Title: |
A subset of high-titer anti-factor VIII A2 domain antibodies is responsive to treatment with factor VIII. |
Volume: |
127 |
Issue: |
16 |
Pages: |
2028-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Siner JI |
Year: |
2013 |
Journal: |
Blood |
Title: |
Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype. |
Volume: |
121 |
Issue: |
21 |
Pages: |
4396-403 |
|
•
•
•
•
•
|
Publication |
First Author: |
Magisetty J |
Year: |
2022 |
Journal: |
Blood |
Title: |
Selective inhibition of activated protein C anticoagulant activity protects against hemophilic arthropathy in mice. |
Volume: |
139 |
Issue: |
18 |
Pages: |
2830-2841 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang AH |
Year: |
2018 |
Journal: |
J Immunol |
Title: |
Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells. |
Volume: |
201 |
Issue: |
5 |
Pages: |
1434-1441 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cooke EJ |
Year: |
2023 |
Journal: |
J Thromb Haemost |
Title: |
Maladaptive lymphangiogenesis is associated with synovial iron accumulation and delayed clearance in factor VIII-deficient mice after induced hemarthrosis. |
Volume: |
21 |
Issue: |
9 |
Pages: |
2390-2404 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ragni MV |
Year: |
2009 |
Journal: |
Exp Hematol |
Title: |
Factor VIII-pulsed dendritic cells reduce anti-factor VIII antibody formation in the hemophilia A mouse model. |
Volume: |
37 |
Issue: |
6 |
Pages: |
744-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Krishnamoorthy S |
Year: |
2016 |
Journal: |
Cell Immunol |
Title: |
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice. |
Volume: |
301 |
|
Pages: |
30-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang AH |
Year: |
2016 |
Journal: |
Cell Immunol |
Title: |
Tolerogenic nanoparticles to induce immunologic tolerance: Prevention and reversal of FVIII inhibitor formation. |
Volume: |
301 |
|
Pages: |
74-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mashausi DS |
Year: |
2022 |
Journal: |
Biochem Biophys Res Commun |
Title: |
A high efficient FVIII variant corrects bleeding in hemophilia A mouse model. |
Volume: |
637 |
|
Pages: |
358-364 |
|
•
•
•
•
•
|
Publication |
First Author: |
Leong L |
Year: |
2015 |
Journal: |
Blood |
Title: |
Noncovalent stabilization of the factor VIII A2 domain enhances efficacy in hemophilia A mouse vascular injury models. |
Volume: |
125 |
Issue: |
2 |
Pages: |
392-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Staber JM |
Year: |
2016 |
Journal: |
PLoS One |
Title: |
Shortened Lifespan and Lethal Hemorrhage in a Hemophilia A Mouse Model. |
Volume: |
11 |
Issue: |
5 |
Pages: |
e0154857 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ohlfest JR |
Year: |
2005 |
Journal: |
Blood |
Title: |
Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system. |
Volume: |
105 |
Issue: |
7 |
Pages: |
2691-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rossi G |
Year: |
2001 |
Journal: |
Blood |
Title: |
Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A. |
Volume: |
97 |
Issue: |
9 |
Pages: |
2750-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Purohit VS |
Year: |
2005 |
Journal: |
J Biol Chem |
Title: |
Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-L-serine complex. |
Volume: |
280 |
Issue: |
18 |
Pages: |
17593-600 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sherman A |
Year: |
2014 |
Journal: |
Blood |
Title: |
Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells. |
Volume: |
124 |
Issue: |
10 |
Pages: |
1659-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ferrière S |
Year: |
2020 |
Journal: |
Blood |
Title: |
A hemophilia A mouse model for the in vivo assessment of emicizumab function. |
Volume: |
136 |
Issue: |
6 |
Pages: |
740-748 |
|
•
•
•
•
•
|
Publication |
First Author: |
Waters B |
Year: |
2009 |
Journal: |
Blood |
Title: |
Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response. |
Volume: |
113 |
Issue: |
1 |
Pages: |
193-203 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sen D |
Year: |
2013 |
Journal: |
J Thromb Haemost |
Title: |
Nuclear factor (NF)-κB and its associated pathways are major molecular regulators of blood-induced joint damage in a murine model of hemophilia. |
Volume: |
11 |
Issue: |
2 |
Pages: |
293-306 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bril WS |
Year: |
2006 |
Journal: |
Thromb Haemost |
Title: |
Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitution. |
Volume: |
95 |
Issue: |
2 |
Pages: |
341-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Evans GL |
Year: |
1998 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A. |
Volume: |
95 |
Issue: |
10 |
Pages: |
5734-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tatsumi K |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
A novel cell-sheet technology that achieves durable factor VIII delivery in a mouse model of hemophilia A. |
Volume: |
8 |
Issue: |
12 |
Pages: |
e83280 |
|
•
•
•
•
•
|
Publication |
First Author: |
Neyman M |
Year: |
2008 |
Journal: |
Blood |
Title: |
Analysis of the spatial and temporal characteristics of platelet-delivered factor VIII-based clots. |
Volume: |
112 |
Issue: |
4 |
Pages: |
1101-8 |
|
•
•
•
•
•
|